+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer

Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer

Journal of Medicinal Food 12(4): 695-703

Lycium barbarum polysaccharides (LBPs) are important functional constituents in red-colored fruits of L. barbarum (Guo Qi Zi, a well-known traditional Chinese medicinal plant commonly known as Goji berry or wolfberry). The influence of LBP on human prostate cancer cells was systematically investigated in vitro and in vivo. The in vitro effects of LBP on two cell lines (PC-3 and DU-145) were examined by using trypan blue exclusion staining, single-cell gel electrophoresis, flow cytometry, terminal dUTP nick-end labeling assay, and immunohistochemical assay (assessment of Bcl-2 and Bax expression). The in vivo effect of LBP on PC-3 cells was assessed in the nude mouse xenograft tumor model. The in vitro results showed that LBP can dose- and time-dependently inhibit the growth of both PC-3 and DU-145 cells. LBP caused the breakage of DNA strands of PC-3 and DU-145 cells; the tail frequency and tail length were significantly higher than that of control cells. LBP also markedly induced PC-3 and DU-145 cell apoptosis, with the highest apoptosis rates at 41.5% and 35.5%, respectively. The ratio of Bcl-2/Bax protein expression following LBP treatments decreased significantly with a dose-effect relationship, which suggested that LBP can regulate the expression of Bcl-2 and Bax to induce apoptosis of PC-3 and DU-145 cells. The in vivo experimental results indicate that LBP might significantly inhibit PC-3 tumor growth in nude mice. Both the tumor volume and weight of the LBP treatment group were significantly lower than those of the control group.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054199317

Download citation: RISBibTeXText

PMID: 19735167

DOI: 10.1089/jmf.2008.1232

Related references

Monoclonal antibody against prostate stem cell antigen inhibits prostate cancer growth and metastasis in a murine xenograft model of prostate cancer. Journal of Urology 165(5 Suppl.): 46, 2001

Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer. International Journal of Radiation Oncology, Biology, Physics 72(3): 935-940, 2008

α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model. ChemoTherapy 63(1): 1-7, 2017

Effects of green tea extract and caffeine on the growth of rat prostate cancer cells and the human prostate cancer xenograft PC346. Proceedings of the American Association for Cancer Research Annual Meeting 44: 954, 2003

Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model. Oncotarget 7(9): 10616-10626, 2016

MLN2704, a chemotherapeutic-conjugated antibody targeting prostate-specific membrane antigen, effectively inhibits the growth of human prostate cancer cells in vitro and in xenograft models. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1291, 2003

Supercritical Fluid Extraction of Citrus iyo Hort. ex Tanaka Pericarp Inhibits Growth and Induces Apoptosis Through Abrogation of STAT3 Regulated Gene Products in Human Prostate Cancer Xenograft Mouse Model. Integrative Cancer Therapies 16(2): 227-243, 2016

Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Molecular Oncology 7(3): 428-439, 2013

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. Urology 53(2): 440-445, 1999

Novel C-4 heteroaryl 13-cis-retinamide Mnk/AR degrading agents inhibit cell proliferation and migration and induce apoptosis in human breast and prostate cancer cells and suppress growth of MDA-MB-231 human breast and CWR22Rv1 human prostate tumor xenografts in mice. Journal of Medicinal Chemistry 58(4): 1900-1914, 2015

REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells. Oncogene 22(19): 2920-2925, 2003

Absence of 5-alpha-reductase in the prostate cancer xenograft CWR22 and prostate cancer cell lines LNCaP, DU145, and MLC-SV40 Failure of finasteride to affect the in vitro growth of CWR22 prostate cancer xenograft. Surgical Forum 47(0): 820-822, 1996

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47(4): 293-303, 2001

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 66(10): 1070-1075, 2006

Soy milk digestion extract inhibits progression of prostate cancer cell growth via regulation of prostate cancer‑specific antigen and cell cycle-regulatory genes in human LNCaP cancer cells. Molecular Medicine Reports 14(2): 1809-1816, 2017